Abstract
Purpose
Home time—being out of any healthcare facility—has been proposed as a patient-centered outcome. This novel measure has not been investigated in patients with chronic kidney disease (CKD). The aim of this study is to determine whether there was an association between home time and occurrence of end-stage renal disease (ESRD) or all-cause mortality during 1 year of follow-up.
Methods
We assembled a prospective cohort of patients with CKD not requiring dialysis at the Nephrology Center of First Affiliated Hospital of Jiaxing University between May 2014 and April 2017 and followed up for 1 year. Home time was calculated as the number of days spent out of a hospital, rehabilitation facility, or skilled nursing facility. Outcomes included progression to ESRD and all-cause mortality.
Results
Among 943 patients, 882 (93.5%) had complete follow-up through 1 year. Mean home time was 246.9 ± 126.7 days. In regression analysis, several patient characteristics were associated with significantly reduced home time, including diabetes mellitus, cardiovascular disease, and albuminuria. Home time was strongly correlated with time-to-event endpoints of ESRD (τ=0.324) and all-cause mortality (τ=0.785).
Conclusions
Home time is significantly reduced for patients with CKD not requiring dialysis and is highly correlated with traditional time-to-event endpoints. Home time serves as a novel, easily calculated, patient-centered outcome that may reflect effect of interventions on future CKD research.
Similar content being viewed by others
Data availability
The present analysis involved routinely collected institutional data.
References
Wang S, Chen R, Liu Q, Shu Z, Zhan S, Li L (2015) Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: the china health and retirement longitudinal study. Nephrology 20(7):474–484. https://doi.org/10.1111/nep.12449
Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815–822. https://doi.org/10.1016/S0140-6736(12)60033-6
Huang YP, Zheng T, Zhang DH, Chen LY, Mao PJ (2016) Community-based study on elderly CKD subjects and the associated risk factors. Ren Fail 38(10):1672–1676. https://doi.org/10.1080/0886022X.2016.1229987
Fukuma S, Kurita N, Fukagawa M, Akizawa T, Fukuhara S (2013) Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan. Kidney Int Suppl 3(5):436–441. https://doi.org/10.1038/kisup.2013.91
Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL (2013) Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis. BMJ 347:f6008. https://doi.org/10.1136/bmj.f6008
Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S (2018) Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis. Am J Kidney Dis 72(1):75–83. https://doi.org/10.1053/j.ajkd.2017.11.018
Wiebe N, Klarenbach SW, Allan GM, Manns BJ, Pelletier R, James MT, Bello A, Hemmelgarn BR, Tonelli M, Alberta Kidney Disease N (2014) Potentially preventable hospitalization as a complication of CKD: a cohort study. Am J Kidney Dis 64(2):230–238. https://doi.org/10.1053/j.ajkd.2014.03.012
Cedillo-Couvert EA, Hsu JY, Ricardo AC, Fischer MJ, Gerber BS, Horwitz EJ, Kusek JW, Lustigova E, Renteria A, Rosas SE, Saunders M, Sha D, Slaven A, Lash JP, Investigators CS (2018) Patient experience with primary care physician and risk for hospitalization in hispanics with CKD. Clin J Am Soc Nephrol 13(11):1659–1667. https://doi.org/10.2215/CJN.03170318
Ishigami J, Grams ME, Chang AR, Carrero JJ, Coresh J, Matsushita K (2017) CKD and risk for hospitalization with infection: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 69(6):752–761. https://doi.org/10.1053/j.ajkd.2016.09.018
Rhee CM, Kovesdy CP (2015) Epidemiology: spotlight on CKD deaths-increasing mortality worldwide. Nat Rev Nephrol 11(4):199–200. https://doi.org/10.1038/nrneph.2015.25
Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE, Mehrotra R, Stevens PE, Wang AY, Cheung M, Wheeler DC, Winkelmayer WC, Pollock CA, Conference P (2019) Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. https://doi.org/10.1016/j.kint.2019.01.017
Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O’Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC, Investigators SIW (2018) Implementing core outcomes in kidney disease: report of the standardized outcomes in nephrology (SONG) implementation workshop. Kidney Int 94(6):1053–1068. https://doi.org/10.1016/j.kint.2018.08.018
Verberne WR, Das-Gupta Z, Allegretti AS, Bart HAJ, van Biesen W, Garcia-Garcia G, Gibbons E, Parra E, Hemmelder MH, Jager KJ, Ketteler M, Roberts C, Al Rohani M, Salt MJ, Stopper A, Terkivatan T, Tuttle KR, Yang CW, Wheeler DC, Bos WJW (2019) Development of an international standard set of value-based outcome measures for patients with chronic kidney disease: a report of the international consortium for health outcomes measurement (ICHOM) CKD working group. Am J Kidney Dis 73(3):372–384. https://doi.org/10.1053/j.ajkd.2018.10.007
Fonarow GC, Liang L, Thomas L, Xian Y, Saver JL, Smith EE, Schwamm LH, Peterson ED, Hernandez AF, Duncan PW, O’Brien EC, Bushnell C, Prvu Bettger J (2016) Assessment of home-time after acute ischemic stroke in medicare beneficiaries. Stroke 47(3):836–842. https://doi.org/10.1161/STROKEAHA.115.011599
Greene SJ, O’Brien EC, Mentz RJ, Luo N, Hardy NC, Laskey WK, Heidenreich PA, Chang CL, Turner SJ, Yancy CW, Hernandez AF, Curtis LH, Peterson PN, Fonarow GC, Hammill BG (2018) Home-time after discharge among patients hospitalized with heart failure. J Am Coll Cardiol 71(23):2643–2652. https://doi.org/10.1016/j.jacc.2018.03.517
Groff AC, Colla CH, Lee TH (2016) Days spent at home-a patient-centered goal and outcome. N Engl J Med 375(17):1610–1612. https://doi.org/10.1056/NEJMp1607206
O’Brien EC, Xian Y, Xu H, Wu J, Saver JL, Smith EE, Schwamm LH, Peterson ED, Reeves MJ, Bhatt DL, Maisch L, Hannah D, Lindholm B, Olson D, Prvu Bettger J, Pencina M, Hernandez AF, Fonarow GC (2016) Hospital variation in home-time after acute ischemic stroke: insights from the PROSPER study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research). Stroke 47(10):2627–2633. https://doi.org/10.1161/STROKEAHA.116.013563
Ariti CA, Cleland JG, Pocock SJ, Pfeffer MA, Swedberg K, Granger CB, McMurray JJ, Michelson EL, Ostergren J, Yusuf S (2011) Days alive and out of hospital and the patient journey in patients with heart failure: insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Am Heart J 162(5):900–906. https://doi.org/10.1016/j.ahj.2011.08.003
McDermid I, Barber M, Dennis M, Langhorne P, Macleod MJ, McAlpine CH, Quinn TJ (2019) Home-time is a feasible and valid stroke outcome measure in national datasets. Stroke 50(5):1282–1285. https://doi.org/10.1161/STROKEAHA.118.023916
O’Brien EC, Greiner MA, Xian Y, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, Smith EE, Maisch L, Hannah D, Lindholm B, Peterson ED, Pencina MJ, Hernandez AF (2015) Clinical effectiveness of statin therapy after ischemic stroke: primary results from the statin therapeutic area of the patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study. Circulation 132(15):1404–1413. https://doi.org/10.1161/CIRCULATIONAHA.115.016183
Yu AYX, Rogers E, Wang M, Sajobi TT, Coutts SB, Menon BK, Hill MD, Smith EE (2017) Population-based study of home-time by stroke type and correlation with modified Rankin score. Neurology 89(19):1970–1976. https://doi.org/10.1212/WNL.0000000000004631
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130(6):461–470
Hernandez AF, Fleurence RL, Rothman RL (2015) The ADAPTABLE trial and PCORnet: shining light on a new research paradigm. Ann Intern Med 163(8):635–636. https://doi.org/10.7326/M15-1460
Anker SD, McMurray JJ (2012) Time to move on from ‘time-to-first’: should all events be included in the analysis of clinical trials? Eur Heart J 33(22):2764–2765. https://doi.org/10.1093/eurheartj/ehs277
Uno H, Claggett B, Tian L, Fu H, Huang B, Kim DH, Wei LJ (2018) Adding a new analytical procedure with clinical interpretation in the tool box of survival analysis. Ann Oncol 29(5):1092–1094. https://doi.org/10.1093/annonc/mdy109
Zipkin DA, Umscheid CA, Keating NL, Allen E, Aung K, Beyth R, Kaatz S, Mann DM, Sussman JB, Korenstein D, Schardt C, Nagi A, Sloane R, Feldstein DA (2014) Evidence-based risk communication: a systematic review. Ann Intern Med 161(4):270–280. https://doi.org/10.7326/M14-0295
Xian Y, Wu J, O’Brien EC, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, Smith EE, Suter RE, Hannah D, Lindholm B, Maisch L, Greiner MA, Lytle BL, Pencina MJ, Peterson ED, Hernandez AF (2015) Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study. BMJ 351:h3786. https://doi.org/10.1136/bmj.h3786
Mishra NK, Shuaib A, Lyden P, Diener HC, Grotta J, Davis S, Davalos A, Ashwood T, Wasiewski W, Lees KR, Stroke Acute Ischemic NXYTIT (2011) Home time is extended in patients with ischemic stroke who receive thrombolytic therapy: a validation study of home time as an outcome measure. Stroke 42(4):1046–1050. https://doi.org/10.1161/STROKEAHA.110.601302
Devins GM, Mendelssohn DC, Barre PE, Binik YM (2003) Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. Am J Kidney Dis 42(4):693–703
Lacson E Jr, Wang W, DeVries C, Leste K, Hakim RM, Lazarus M, Pulliam J (2011) Effects of a nationwide predialysis educational program on modality choice, vascular access, and patient outcomes. Am J Kidney Dis 58(2):235–242. https://doi.org/10.1053/j.ajkd.2011.04.015
Ricardo AC, Anderson CA, Yang W, Zhang X, Fischer MJ, Dember LM, Fink JC, Frydrych A, Jensvold NG, Lustigova E, Nessel LC, Porter AC, Rahman M, Wright Nunes JA, Daviglus ML, Lash JP, Investigators CS (2015) Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis 65(3):412–424. https://doi.org/10.1053/j.ajkd.2014.09.016
Funding
This work was funded by a grant from the Jiaxing Municipal Sci-Tech Bureau Program (2018AD32066).
Author information
Authors and Affiliations
Contributions
JZ conceived and designed the study; HW and HY prepared the samples and analyzed the data; LZ drafted the paper; JZ revised the paper. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Ethical approval
The Ethics Committee of First Affiliated Hospital of Jiaxing University approved study protocols which adhered to the Declaration of Helsinki.
Informed consent
Written informed consents were obtained from all participants prior to enrollment.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, L., Wu, HL., Yu, HF. et al. Time spent outside of the hospital, CKD progression, and mortality: a prospective cohort study. Int Urol Nephrol 53, 1659–1663 (2021). https://doi.org/10.1007/s11255-020-02749-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02749-8